EDAP to Present at the Jefferies Global Healthcare Conference
EDAP to Present at the Jefferies Global Healthcare Conference
LYON, France, May 22, 2024 -- EDAP TMS SA (Nasdaq: EDAP) ("the Company"), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a presentation and host 1x1 investor meetings at the Jefferies Global Healthcare Conference, which is being held June 5-6, 2024, in New York City.
法國里昂，2024年5月22日——機器人能量療法領域的全球領導者EDAP TMS SA（納斯達克股票代碼：EDAP）（“公司”）今天宣佈，首席執行官瑞安·羅德斯計劃在2024年6月5日至6日在紐約市舉行的傑富瑞全球醫療保健會議上發表演講並主持1x1投資者會議。
Presentation details:
演示詳情：
| Date: | Wednesday, June 5th |
| Time: | 7:30 AM ET |
| Webcast: | https://wsw.com/webcast/jeff302/edap/1814176 |
| 日期： | 6月5日，星期三第四 |
| 時間： | 美國東部時間上午 7:30 |
| 網絡直播： | https://wsw.com/webcast/jeff302/edap/1814176 |
The live and archived webcast of the presentation can be accessed in the Investors section of the Company's website here.
可以在公司網站的 “投資者” 部分觀看該演講的直播和存檔網絡直播 這裏。
About EDAP TMS SA
關於 EDAP TMS SA
A recognized leader in the global therapeutic ultrasound market, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One in Europe and in the U.S. as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVu Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer. EDAP TMS also produces and distributes other medical equipment including the Sonolith i-move lithotripter and lasers for the treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL). For more information on the Company, please visit http://www.edap-tms.com, us.hifu-prostate.com and www.focalone.com.
作爲全球超聲治療市場公認的領導者，EDAP TMS使用超聲技術在全球範圍內開發、製造、推廣和分銷用於各種病理的微創醫療設備。通過在其全系列機器人 HIFU 設備中結合成像和治療模式方面的最新技術，EDAP TMS 推出了 Focal One 在歐洲和美國，可以滿足理想的前列腺組織消融的所有要求。隨着ExactVu微超設備的加入，EDAP TMS現在是唯一一家提供從診斷到前列腺癌局部治療的完整解決方案的公司。EDAP TMS 還生產和分銷其他醫療設備，包括 Sonolith i-move 碎石機和激光器使用體外衝擊波碎石術（ESWL）治療尿路結石。如需了解有關公司的更多信息，請訪問 http://www.edap-tms.com， us.hifu-prostate.com 和 www.focalone.com。
Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com
公司聯繫人
Blandine Confort
投資者關係 /法律事務
DEAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com
Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com
投資者聯繫人
約翰·弗朗西斯
LifeSci 顧問有限公司
(917) 355-2395
jfraunces@lifesciadvisors.com
譯文內容由第三人軟體翻譯。